US Pharmaceutical, Medical Device, Diagnostics Markets

US Pharmaceutical, Medical Device, Diagnostics Markets


December 1, 2011
35 Pages - SKU: KLI6077623
License type:
Online Download      US $500.00
Global Site License      US $1,000.00
Countries covered: United States

Kalorama Information reports on a wide range of topics related to healthcare industry markets in the United States. This report, The Kalorama U.S.Pharmaceutical, Medical Device, Diagnostics Markets provides a broad look at the healthcare system and a summary of the market for the healthcare industry in the United States. The report discusses a range of topics impacting the industry:
  • Healthcare Reform - What Impact Will Be Had on Each Healthcare Industry? How Will Physicians, Patients, Payors, and the Uninsured Be Affected?
  • How Does U.S. Public Spending Rate with Other Countries?
  • Consolidation - How will increasing Service Provider and Manufacturer mergers Shape the Industry?
  • IT Systems - Burden or Blessing?
  • Physician Shortages and Morale - Is the Industry and Government Confronting These Problems?
  • Statistics - what are the most common Hospital Discharges in the US? What specialists are visited most often?
  • What are the Highest Growth and Highest Interest Areas of Healthcare in 2011?
In addition, provides top-level U.S. market size estimates for the following markets:
  • Pharmaceutical Market
  • Diagnostics Market
  • Medical Device Market
  • Healthcare IT Market
This report was compiled from secondary and primary research sources and using Kalorama's research on healtcare markets compiled recently. It is intended as an overview - Kalorama Information has market reports that go into further detail on specific pharmaceutical, testing and device markets.

Readers of the report will develop an understanding of the state of the U.S. healthcare market in 2011 and have top-level numbers for business planning purposes. Because of the broad nature of the report, Kalorama Information cannot field questions on the report after purchase but can suggest titles that may answer research questions. This report cannot be sold in sections.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/




More Research & Development reports by Kalorama Information

The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs) by Kalorama Information
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The ...
The World Market for Pain Management Drugs and Devices by Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain ...
The Next Wave In Cancer Treatment - Kinase Inhibitors by Kalorama Information
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. ...
Kalorama Vaccine Market Research Report Bundle (Vaccines 2012, What's Next in Vaccines, Vaccine Production Markets) by Kalorama Information
Vaccines are an important part of the business model of top pharmaceutical companies. The success of several recent vaccine product introductions has been of ...
See all reports like this >>

More United States Research & Development reports

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 541712 by Plunkett Research, Ltd.
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics andRevenue Forecasts to 2020, NAIC 541712Vital ...
Research and Development in the Physical, Engineering and Life Sciences Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 541710 by Plunkett Research, Ltd.
Research and Development in the Physical, Engineering and Life Sciences Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 541710Vital industry-specific ...
Scientific Research & Development in the US - Industry Risk Rating Report by IBISWorld
Scientific Research & Development in the US - Industry Risk Rating ReportIBISWORLD INDUSTRY RISK RATINGS REPORT This Industry Risk Ratings report from IBISWorld evaluates the ...
Pharmaceutical Contract Management Consulting in the US - Industry Market Research Report by IBISWorld
Pharmaceutical Contract Management ConsultingThe Pharmaceutical Contract Management Consulting industry is expected to experience growth over the five years to 2014. Demand hardly faltered during the ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>